News overview

• Q3 EBITDA from continuing operations €339 million, 26% ahead of Q3 2010
• Organic sales growth 14%
• Robust performance in Life Sciences despite significant impact of Swiss franc
• Very good Materials Sciences results driven by Polymer Intermediates
• Martek continued its excellent performance; integration completed
• DSM Sinochem Pharmaceuticals joint venture established
• EPS (before exceptional items, continuing operations) up 38% to €0.94
• Outlook confirmed: 2011 expected to be a strong year

Royal DSM N.V., the global Life Sciences and Materials Sciences company, and KuibyshevAzot OJSC (KA) today announce they have commenced their strategic cooperation, as announced in January 2011. As a result of this strategic cooperation, DSM Engineering Plastics has two joint ventures with KA. In both joint ventures DSM Engineering Plastics holds a majority share. In addition, KA has received a license under DSM Fibre Intermediates' technology for the production of cyclohexanone.

• Vision 2010 strategy successfully completed; DSM will now drive focused growth
• Q4 operating profit from continuing operations up 17% to € 170 million
• Full-year operating profit from continuing operations up 74% to € 752 million
• Very good Nutrition performance drives Life Sciences results
• Significant improvement in Materials Sciences results
• Continued strong cash flow from operating activities of € 1.1 billion in 2010
• Dividend increase of 12.5% to € 1.35 per ordinary share proposed for 2010
• 2011 is expected to be another strong year for DSM towards achieving the 2013 targets

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announced today that it has signed an agreement to acquire the majority shareholding in Shandong ICD High Performance Fibre Co Ltd. ("ICD"), based in Laiwu, Shandong province, China.  Closing of this transaction is expected in the course of 2011.

DSM Engineering Plastics today announces that five of its performance materials have been awarded Cradle to Cradle^® certification by the internationally renowned sustainable design firm, McDonough Braungart Design Chemistry (MBDC).

The Netherlands-based DSM and the Japan-based National Institute for Materials Science (NIMS) announced today the agreement on collaborative research in biomedical-related material science, initially focusing on the joint development of biocompatible materials with bio-inactive surface that inhibit protein adsorption and cell adhesion.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces a major breakthrough in the technology to produce second generation biofuels. This breakthrough will help second generation biofuels to become more cost effective and to become a viable alternative to both first generation biofuels and conventional fossil fuels.

DSM Engineering Plastics, a business group of the Netherlands-based Life Sciences and Materials Sciences company Royal DSM N.V., today announces that it has completed the acquisition of Mitsubishi Chemical Corporation’s (MCC) Novamid^® polyamide business in exchange for DSM’s Xantar^® polycarbonate business.

DSM Engineering Plastics, a business group of the Netherlands-based Life Sciences and Materials Sciences company Royal DSM N.V., today announces that it has signed the contracts with Mitsubishi Chemical Corporation (MCC) enabling DSM to acquire MCC’s Novamid^® polyamide business in exchange for DSM’s Xantar^® polycarbonate business.

DSM Functional Coatings today announced the further optimization of its KhepriCoat™
solar anti-reflective coating system. The improvements have already resulted in a
significant contribution to the first multicrystalline-silicon solar panels in the world to
achieve a conversion efficiency of 17%, which were produced recently by REC and ECN
(Energy research Center of the Netherlands).

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and Novomer Inc., based in Waltham (Massachusetts, United States), today announce that they have signed an agreement to jointly develop a revolutionary coating resin using carbon dioxide (CO2) as a raw material.

DSM Specialty Intermediates B.V. (DSI) in Sittard (Netherlands) has today announced the intention to discontinue its operational activities by 31 December 2010 at the latest. As a consequence, DSI's production activities at the Chemelot industrial site in Sittard-Geleen will be stopped with effect from 1 July 2010. The closure will result in the loss of 37 jobs at DSI. DSM strives to avoid forced redundancies as much as possible. DSM has asked the local Works Council for advice on the intended closure.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and Shaw Industries Group, Inc. announce today that DSM has acquired full control of the PA6 polymerization facility of Nylon Polymer Company LLC (NPC) in Augusta (Georgia, United States). Shaw Industries and DSM Chemicals North America were previously joint venture partners in NPC.

• Q3 operating profit from continuing operations EUR 139 million, more than double Q2 2009 (EUR 58 million)
• Strong Life Sciences performance due to robust Nutrition business
• Materials Sciences continued strong recovery
• Cost savings and efficiency improvements on track to achieve EUR 150 - 200 million on yearly basis by 2010
• Cash flow from operating activities again very strong (Q3 EUR 517 million)
• Outlook for the rest of the year remains uncertain; Q4 operating profit currently expected to be lower than Q3, but above Q4 last year

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that its KhepriCoat(TM) anti-reflective coating system has contributed to achieving the highest energy conversion ever of a full-size solar module.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, has regained its number one position in the chemical industry sector in the Dow Jones Sustainability World Index*, published today. From 2004 to 2006 DSM was named the worldwide sustainability No. 1 in this sector. In 2007 and 2008 it ranked amongst the top leaders in the sector.

• Q2 operating profit from continuing operations clearly higher than Q1 2009

• Q2 total operating profit of EUR 79 million, substantially down from last year's record

• Nutrition business remains robust

• Materials Sciences recovers from first quarter losses

• Cash flow from operating activities once again very strong (EUR 267 million); 44% higher than Q2 2008

• Interim dividend unchanged at EUR 0.40 per ordinary share

• The outlook remains uncertain, although the initial impact of inventory write-downs and customer de-stocking now looks to be largely over 

DSM Engineering Plastics has expanded further its Green Portfolio with the introduction of EcoPaXX™, a bio-based, high performance engineering plastic. The new material, which is based on polyamide (PA) 410, has been developed by DSM in recent years, and is now set to be commercialized.

New DSM Stanyl® thermally conductive materials replace aluminum housing in Philips MASTER LED MR16 retrofit lamp

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces an agreement to acquire Biopract GmbH, based in Berlin (Germany). The acquisition of privately held Biopract will serve as an entry point for DSM into the promising biogas market, which is showing 15-20% growth per year.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has entered into a multi-million dollar contract with Shire US Manufacturing Inc., a subsidiary of Shire plc., for the manufacture and supply of specialty pharmaceutical products to Shire.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologics delivery system developed by MediVas LLC. Integrated into DSM's Trancerta® Drug Delivery platform, this will open up a broad range of opportunities for next generation drug delivery. DSM's activities in this field are an illustration of the way DSM is leveraging its competences in Materials Sciences into Life Sciences applications.

Royal DSM NV, the world's leading Life and Materials Sciences company, announced today a scientific breakthrough in tackling iron deficiency and malaria in partnership with the World Food Programme. It has found a new way to resolve a longstanding nutrition problem - using its enzyme expertise to provide iron to those suffering from iron deficiency, without increasing the risk of malaria.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces that today a new factory for waterborne acrylic resins has been opened in Waalwijk (Netherlands). Total investment costs amounted to EUR 30 million.

• Full year operating profit up 10% to EUR 903 million; Q4 down 35% to EUR 123 million

• Continuing strong performance from Life Sciences businesses and DSM Dyneema in Q4

• Most Materials Sciences businesses severely impacted by downturn since beginning of Q4

• Focus on cash over profitability generates strong cash flow in Q4; cost saving program of EUR 100 million under way

• Solid long-term financial position; dividend maintained at EUR 1.20 per share

• No quantitative outlook provided for 2009 in view of the uncertain economic conditions